These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32750572)

  • 61. An exploratory, randomized controlled trial of adherence therapy for people with schizophrenia.
    Anderson KH; Ford S; Robson D; Cassis J; Rodrigues C; Gray R
    Int J Ment Health Nurs; 2010 Oct; 19(5):340-9. PubMed ID: 20887608
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.
    Robinson D; Woerner MG; Alvir JM; Bilder R; Goldman R; Geisler S; Koreen A; Sheitman B; Chakos M; Mayerhoff D; Lieberman JA
    Arch Gen Psychiatry; 1999 Mar; 56(3):241-7. PubMed ID: 10078501
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of Adjunctive Raloxifene Therapy on Severity of Refractory Schizophrenia in Women: A Randomized Clinical Trial.
    Kulkarni J; Gavrilidis E; Gwini SM; Worsley R; Grigg J; Warren A; Gurvich C; Gilbert H; Berk M; Davis SR
    JAMA Psychiatry; 2016 Sep; 73(9):947-54. PubMed ID: 27438995
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Exploratory study of once-daily transcranial direct current stimulation (tDCS) as a treatment for auditory hallucinations in schizophrenia.
    Fröhlich F; Burrello TN; Mellin JM; Cordle AL; Lustenberger CM; Gilmore JH; Jarskog LF
    Eur Psychiatry; 2016 Mar; 33():54-60. PubMed ID: 26866874
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Examining the validity of DSM-III-R schizoaffective disorder and its putative subtypes in the Roscommon Family Study.
    Kendler KS; McGuire M; Gruenberg AM; Walsh D
    Am J Psychiatry; 1995 May; 152(5):755-64. PubMed ID: 7726316
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A randomized controlled trial of the illness management and recovery program for persons with schizophrenia.
    Färdig R; Lewander T; Melin L; Folke F; Fredriksson A
    Psychiatr Serv; 2011 Jun; 62(6):606-12. PubMed ID: 21632728
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Stability of personality traits in schizophrenia and schizoaffective disorder: a pilot project.
    Kentros M; Smith TE; Hull J; McKee M; Terkelsen K; Capalbo C
    J Nerv Ment Dis; 1997 Sep; 185(9):549-55. PubMed ID: 9307616
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder.
    Emsley RA; Oosthuizen PP; Joubert AF; Roberts MC; Stein DJ
    J Clin Psychiatry; 1999 Nov; 60(11):747-51. PubMed ID: 10584762
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Psychopathological and social status of patients with affective, schizophrenic and schizoaffective disorders after long-term course.
    Marneros A; Deister A; Rohde A
    Acta Psychiatr Scand; 1990 Nov; 82(5):352-8. PubMed ID: 2281805
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Tunisian mothers' beliefs about their child's first psychotic episode].
    Bourgou S; Halayem S; Bouden A; Halayem MB
    Encephale; 2012 Dec; 38(6):473-9. PubMed ID: 23200613
    [TBL] [Abstract][Full Text] [Related]  

  • 71. How do socio-demographic and clinical factors interact with adherence attitude profiles in schizophrenia? A cluster-analytical approach.
    Beck EM; Cavelti M; Wirtz M; Kossowsky J; Vauth R
    Psychiatry Res; 2011 May; 187(1-2):55-61. PubMed ID: 21074860
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of text messages to improve health literacy on medication adherence in patients with type 2 diabetes mellitus: A randomized controlled pilot trial.
    Sugita H; Shinohara R; Yokomichi H; Suzuki K; Yamagata Z
    Nagoya J Med Sci; 2017 Aug; 79(3):313-321. PubMed ID: 28878436
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.
    Ciapparelli A; Dell'Osso L; Bandettini di Poggio A; Carmassi C; Cecconi D; Fenzi M; Chiavacci MC; Bottai M; Ramacciotti CE; Cassano GB
    J Clin Psychiatry; 2003 Apr; 64(4):451-8. PubMed ID: 12716249
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Could schizoaffective disorder, schizophrenia and bipolar I disorder be distinguishable using cognitive profiles?
    Chen CK; Lee CY; Lee Y; Hung CF; Huang YC; Lee SY; Huang MC; Chong MY; Chen YC; Wang LJ
    Psychiatry Res; 2018 Aug; 266():79-84. PubMed ID: 29852325
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Schizoaffective disorder: clinical aspects, differential diagnosis, and treatment.
    Marneros A
    Curr Psychiatry Rep; 2003 Jul; 5(3):202-5. PubMed ID: 12773273
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Neurocognitive functioning and outcome of the Illness Management and Recovery Program for clients with schizophrenia and schizoaffective disorder.
    Färdig R; Fredriksson A; Lewander T; Melin L; Mueser KT
    Nord J Psychiatry; 2016 Aug; 70(6):430-5. PubMed ID: 26936087
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Insight into illness in schizophrenia, schizoaffective disorder, and mood disorders with psychotic features.
    Pini S; Cassano GB; Dell'Osso L; Amador XF
    Am J Psychiatry; 2001 Jan; 158(1):122-5. PubMed ID: 11136644
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impact of a text messaging pilot program on patient medication adherence.
    Foreman KF; Stockl KM; Le LB; Fisk E; Shah SM; Lew HC; Solow BK; Curtis BS
    Clin Ther; 2012 May; 34(5):1084-91. PubMed ID: 22554973
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The impact of self-stigmatization on medication attitude in schizophrenia patients.
    Feldhaus T; Falke S; von Gruchalla L; Maisch B; Uhlmann C; Bock E; Lencer R
    Psychiatry Res; 2018 Mar; 261():391-399. PubMed ID: 29353769
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Insight and recovery from psychosis in chronic schizophrenia and schizoaffective disorder patients.
    Smith TE; Hull JW; Huppert JD; Silverstein SM; Anthony DT; McClough JF
    J Psychiatr Res; 2004; 38(2):169-76. PubMed ID: 14757331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.